Kimia Farma Executive and Leadership Team

Muh Syulhasbiullah, the Chief Executive Officer at Kimia Farma, directs the company's overall strategic vision and operational execution. Overseeing all major business units, Muh Syulhasbiullah ensures alignment with the company's mission to produce, market, and distribute pharmaceutical preparations. This leadership role involves navigating the complex Indonesian pharmaceutical landscape, driving innovation in chemical production, and expanding market reach. By fostering cross-departmental collaboration, Muh Syulhasbiullah guarantees that Kimia Farma's operations meet stringent quality standards and regulatory requirements. The Chief Executive Officer's focus remains on sustainable growth and enhancing the company's contribution to public health through reliable chemical supply chains. Muh Syulhasbiullah's strategic guidance is pivotal in maintaining Kimia Farma's competitive edge and market leadership.

Indah Suciarti, the Founder & Chief Executive Officer at Kimia Farma, established the company's foundational principles and continues to shape its long-term trajectory. Guiding the executive team, Indah Suciarti ensures the company's core mission of producing, marketing, and distributing pharmaceutical preparations remains paramount. This leadership position involves setting the ethical framework and strategic direction for all Kimia Farma's endeavors. By championing a culture of excellence and innovation, Indah Suciarti drives the company's commitment to quality and accessibility in the Indonesian market. The Founder & Chief Executive Officer's vision extends to fostering robust partnerships and expanding the company's impact on national health initiatives. Indah Suciarti's enduring influence is critical in maintaining Kimia Farma's legacy and its forward-looking approach to pharmaceutical chemical distribution.

Ima Hermayani, the Chief Financial Officer at Kimia Farma, manages the company's financial health and strategic fiscal planning. Overseeing all financial operations, including accounting, budgeting, and investment, Ima Hermayani ensures robust financial controls and compliance with Indonesian fiscal regulations. This critical role involves providing financial insights to support executive decision-making, optimizing capital allocation, and managing financial risks. By maintaining strong relationships with financial institutions, the Chief Financial Officer secures the necessary funding for Kimia Farma's operational expansion and product development initiatives. Ima Hermayani's strategic financial management is essential for the company's sustained profitability and long-term economic stability. The Chief Financial Officer's diligence safeguards Kimia Farma's assets and enhances shareholder value.

Faridz Wiradika, the Chief Operating Officer at Kimia Farma, oversees the day-to-day operational activities and ensures seamless execution of production and distribution processes. Managing the company's manufacturing facilities and supply chain logistics, Faridz Wiradika drives efficiency and quality across all operational touchpoints. This leadership role is fundamental to maintaining the integrity of Kimia Farma's chemical production for pharmaceutical preparations. By optimizing resource utilization and streamlining workflows, the Chief Operating Officer enhances productivity and reduces operational costs. Faridz Wiradika's focus includes implementing best practices in manufacturing and distribution to meet market demands reliably. The Chief Operating Officer's commitment to operational excellence ensures Kimia Farma consistently delivers high-quality products to its clients.

Muminatus Solikha, the President Director at Kimia Farma, holds a key leadership position responsible for driving corporate governance and strategic oversight. Working closely with the board of directors, Muminatus Solikha ensures that Kimia Farma operates with the highest standards of integrity and compliance. This role involves guiding the executive team in executing the company's strategic objectives and fostering a culture of accountability. By championing ethical business practices, the President Director contributes to Kimia Farma's reputation and long-term sustainability. Muminatus Solikha's leadership ensures that the company's operations align with its mission to provide essential pharmaceutical chemicals. The President Director's influence is vital in maintaining stakeholder confidence and driving responsible corporate growth.

Nita Monalisa, the President Director at Kimia Farma, plays a pivotal role in shaping the company's strategic direction and ensuring effective corporate governance. Collaborating with the board and executive leadership, Nita Monalisa focuses on enhancing operational effectiveness and market positioning. This position requires a deep understanding of the pharmaceutical industry landscape in Indonesia and a commitment to upholding regulatory standards. By driving strategic initiatives, the President Director supports Kimia Farma's mission to produce and distribute vital pharmaceutical preparations. Nita Monalisa's leadership emphasizes sustainable business practices and stakeholder engagement. The President Director's oversight is crucial for maintaining Kimia Farma's commitment to quality and its contribution to public health.

Yodi Fakhri, the Chief Technology Officer at Kimia Farma, architects the company's technological infrastructure and digital transformation initiatives. Overseeing all IT operations and research and development in technology, Yodi Fakhri ensures that Kimia Farma leverages cutting-edge solutions for chemical production and distribution. This role is crucial for enhancing operational efficiency, ensuring data security, and driving innovation in pharmaceutical preparation processes. By implementing advanced systems, the Chief Technology Officer supports the company's ability to meet evolving market demands and regulatory standards. Yodi Fakhri's strategic focus includes exploring new technologies that can optimize the supply chain and improve the quality of chemical inputs for pharmaceuticals. The Chief Technology Officer's leadership ensures Kimia Farma remains at the forefront of technological adoption within the Indonesian pharmaceutical sector.

Drajad Wahyudi, the Chief Marketing Officer at Kimia Farma, spearheads the company's market presence and brand strategy. Directing all marketing and sales functions, Drajad Wahyudi ensures that Kimia Farma's pharmaceutical chemical products reach their target audiences effectively across Indonesia. This leadership position involves developing comprehensive go-to-market strategies, analyzing market trends, and identifying new business opportunities. By enhancing brand visibility and customer engagement, the Chief Marketing Officer supports the company's revenue growth and market share expansion. Drajad Wahyudi's efforts are focused on communicating the value and quality of Kimia Farma's offerings to healthcare providers and pharmaceutical manufacturers. The Chief Marketing Officer's expertise is vital in navigating the competitive landscape and reinforcing Kimia Farma's position as a trusted supplier.